Paul Fehlner

Paul Fehlner

Corporate Officer/Principal presso SPYRE THERAPEUTICS, INC.
63 anni
Commercial Services
Health Technology
Consumer Services

Profilo

Paul Fehlner was the founder of Life Sciences Innovation LLC, founded in 2017, holding the title of Principal.
Dr. Fehlner is also the founder of ReVision Therapeutics, Inc...
Dr. Fehlner is Senior VP & Chief Intellectual Property Counsel at Spyre Therapeutics, Inc. since 2023.
Former positions include Associate & Principal at Darby & Darby, Associate at Klauber & Jackson Llc, Global Head-Intellectual Property at Novartis Pharma AG from 2008 to 2017, Secretary, Chief Legal Officer & Senior VP at Axcella Health, Inc. from 2021 to 2023, and Partner at Baker Botts LLP from 2006 to 2008.
Education includes graduate degree from Fordham University in 1994, undergraduate degree from Haverford College in 1985, and doctorate from The Rockefeller University in 1990.

Posizioni attive di Paul Fehlner

SocietàPosizioneInizio
SPYRE THERAPEUTICS, INC. Corporate Officer/Principal 27/11/2023

Precedenti posizioni note di Paul Fehlner

SocietàPosizioneFine
AXCA HEALPAR Consigliere Generale 01/11/2023
Corporate Officer/Principal 01/11/2017
Corporate Officer/Principal 01/01/2008
Fondatore -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Paul Fehlner

Formazione di Paul Fehlner

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

88

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private11

Retail Trade

Health Technology

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Life Sciences Innovation LLC

  1. Mercati
  2. Insiders
  3. Paul Fehlner